In this study, we also detected emergency of EGFR T790M mutation in NSCLC PC-9 cells exposed to chronic treatment of gefitinib, and in the established gefitinib-resistant PC-9-GR cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.